⬆
X
By continuing to use the site, you allow the use of Cookies and agree to the privacy policy.
.,о.,р..и.:г,.и.,н.;н.,а;,л.. .,н.:а,.х.,о.,д.;и.,т..с.:я,, ..н.;а., .,k;,i..b.:e,;r.,i.,s.,.;.r.:u,

Comparison results

 
Results: Differences General ✘C96.2✘Paraneoplastic dermatoses
Related research Analogs Analogs
Register, to see more distinctive signs of diseases and studies 100%(0)29%(0)
Other hormones 14%(1)35%(1)
Coagulogram —48%(2)
Blood biochemistry 12%(0)30%(0)
Histological studies —40%(0)
MRI of the organ 11%(0)28%(0)
Ultrasound of the organ 11%(0)27%(0)
CT of the organ 11%(0)27%(0)
Distinctive symptoms
Register, to see more distinctive signs of diseases and studies 49%—
Register, to see more distinctive signs of diseases and studies —100%
feeling of fullness 26% —
during 's dermatitis — 87%
myelofibrosis 22% —
bullous pemphigoid — 87%
chronic myeloid leukemia 20% —
dermatosis — 85%
myeloid metaplasia 20% —
skin cancer — 82%
chronic leukemia 19% —
bullous dermatitis — 82%
hemorrhagic syndrome 17% —
pemphigoid — 78%
multiple organ failure 16% —
blisters — 77%
blood diseases 15% —
rashes itchy — 77%
aggressive 13% —
itchy skin — 74%
acute condition 12% —
erythematous pemphigus — 68%
control issues 12% —
dermatitis — 66%
patient's condition 11% —
carcinoid syndrome — 64%
amyloidosis of the skin — 64%
black acanthosis — 61%
late cutaneous porphyria — 58%
liver amyloidosis — 58%
bubbles itchy — 58%
can't refuse — 57%
history of surgery — 56%
paraneoplastic dermatoses — 56%
breast cancer — 56%
solid tumors — 55%
breast tumor — 54%
is quickly irritated — 52%
recurrent urticaria — 52%
itchy eczema — 51%
vesicular dermatitis — 50%
skin problems 11% 60%
porphyria — 49%
gardner syndrome — 49%
itchy dermatitis — 49%
stevens-johnson syndrome — 49%
reddening of the skin — 48%
radiation dermatitis — 48%
erythroderma — 48%
urticaria itching — 48%
fear of responsibility — 47%
dermatitis unspecified — 47%
metastases — 47%
inflammation — 45%
abrasion — 44%
rashes of the sole — 44%
rashes on the palms — 44%
rashes on the hands and feet — 44%
rapid weight loss — 44%
loss body weight — 44%
urticaria skin — 44%
rashes bubbles — 43%
bullous emphysema of the lung — 43%
itching constant — 43%
bubbles on the skin — 43%
seborrhea — 43%
skin dystrophy — 43%
cytolysis syndrome — 42%
keratodermia — 42%
neurofibroma — 42%
severe itching of the skin — 42%
pimples on the face — 42%
cancer 23% 65%
rash on the wrists — 41%
necrosis — 41%
amyloidosis — 41%
lung cyst — 41%
acne — 41%
oncology 19% 59%
urticaria — 40%
skin irritation — 40%
rashes on the hands — 40%
dermatitis and eczema — 40%
acne face — 40%
rashes on his legs — 39%
eczema — 39%
bruise — 38%
Common symptoms are weakness — 38%
oncology relatives — 38%
liebman-sachs endocarditis — 37%
brown spots on the skin — 36%
the skin is dark — 36%
omission of internal organs — 36%
rashes on the face — 36%
brown pigmentation after rashes — 36%
endocarditis — 35%
elderly patients — 35%
protein with increased — 33%
oncology in the anamnesis — 33%
high height — 33%
skin spots — 33%
general weakness — 33%
benign neoplasms — 32%
periods of exacerbation — 32%
papules — 32%
radiation therapy — 32%
radiation damage — 31%
changes in the blood — 31%
cysts — 31%
vascular tumor — 31%
dystrophy — 31%
imbalance — 30%
liver problems — 30%
k94 diagnosis of gastrointestinal diseases — 29%
drug disease — 28%
impaired lung function — 28%
trauma — 27%
increased 10% 36%
consequences of taking medications 11% 26%
leukemia 27% 38%

Instructions

Video
  1. Introduce new diseases through 🔍 Search and input on the top panel using
  2. The table shows the most important distinguishing symptoms, tests and diagnoses related to the selected diseases.
  3. The higher the percentage, the more important this symptom is for the disease and vice versa. At 0%, we can say that this symptom never occurs in the disease.
  4. The list changes dynamically depending on the data of the current visit in the selection of therapy .
  5. Click on the percentageto see the suggestions from the original source.
  6. By using the service, you agree to user agreement.